Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency.
Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.
Early Detection Research Program, Alzheimer's Disease, Pasqual Maragall Foundation, Barcelona, Spain. rfdalre@gmail.com
Rafael
R
Dal-Ré
David
D
Moher
Christian
C
Gluud
Shaun
S
Treweek
Jacques
J
Demotes-Mainard
Xavier
X
Carné
D035843:Biomedical Research / Q000941:ethics; D002986:Clinical Trials as Topic / Q000941:ethics; D016265:Conflict of Interest; D030881:Disclosure / Q000941:ethics; D006801:Humans; D015337:Multicenter Studies as Topic / Q000941:ethics; D018579:Patient Selection / Q000941:ethics; D012108:Research Personnel / Q000941:ethics*